NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/13/2026

1. ADBE
2. SPCX
3. USO
4. SPY
5. RH
6. NVDA
7. RKLB
8. CRM
9. MSFT
10. DLMAF

Go back to NeoGenomics Reports 159% Revenue growth to $59.7 Million and 442% Adjusted EBITDA increase to $8.2 Million, Driven by Clarient acquisition and Strong Volume Gains
NEOGENOMICS (NASDAQ: NEO) Delayed: 11.15 -0.32 (2.79%)
Previous Close $11.47    52 Week High $9.54 
Open $11.49    52 Week Low $5.49 
Day High $11.57    P/E 278.75 
Day Low $10.99    EPS $0.04 
Volume 1,481,056